United BioSource Corporation (UBC) today announced the opening of its
newest global office in Tokyo, Japan. The UBC office will be led by
Kumpei Kobayashi, PharmD, a biopharmaceutical industry veteran with over
20 years of product development experience throughout the Asia-Pacific
region. Personnel in the new UBC office will support the company’s
investigator training and certification solutions as well as ongoing
clinical research monitoring services in the region.
“We believe it is absolutely critical to provide clients with
on-the-ground biopharmaceutical research scientists and operations
professionals with local knowledge and expertise”
The new facility reinforces UBC’s position as the industry leader in
helping biopharmaceutical research sponsors protect the integrity of
clinical trial data and enhance research measurement precision to ensure
the reliability of study results. The company’s increased commitment in
the Asia-Pacific region underscores the growing importance of domestic
Japanese and Pan-Asian clinical research studies as a crucial success
factor during regulatory evaluations and product commercialization.
“We believe it is absolutely critical to provide clients with
on-the-ground biopharmaceutical research scientists and operations
professionals with local knowledge and expertise,” said Catherine Spear,
UBC’s Senior Vice President. “The UBC office in Tokyo will help us
support our clients’ research projects with local personnel who
understand the needs of patients, health care professionals and
regulators in this important region. Local knowledge of the Asia-Pacific
markets is absolutely essential when we help clients manage research
projects that are often very large, complex and supported by significant
financial investments.”